2026 NPPES data Oncology Registered Nurse NPI 1518333202 NP
Verify on CMS →

ANALUISA LARES, NP

Oncology Registered Nurse in STANFORD, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
50
Medicare Part D claims · 16 beneficiaries · Oncology Registered Nurse avg: 555
MIPS score
76.5025/100
▼ 7 pts below national avg 83.1 · [object Object]
What the federal data reveals: ANALUISA LARES, NP is a Oncology Registered Nurse ([object Object]) practicing in STANFORD, California with a Medicare Part D prescribing footprint of 50 claims across 16 beneficiaries . Their CMS MIPS Final Score of 76.5025/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: ANALUISA LARES, NP reported a CMS MIPS final score of 76.5025 out of 100, below the 83.1 national average, and filed 50 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ANALUISA LARES, NP at a glance

Below national average

NPI registry status

Active

Issued 08/17/2015

NPI 1518333202

Primary specialty

Oncology Registered Nurse

Niche

857 US NPIs in this specialty

Medicare Part D claims

50 91% vs specialty avg

2023 prescription claims

Specialty avg: 555

MIPS final score

76.5025/100 6.597499999999997% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Oncology Registered Nurse compares to other specialties among California providers

California providers

Oncology Registered Nurse share within California

1. Oncology Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Registered Nurse share within California

Medicare quality performance — MIPS

ANALUISA LARES, NP's 2023 MIPS final score plotted against the Oncology Registered Nurse national average

Below national average
MIPS Final Score
76.5025/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Oncology Registered Nurse) — 76.5025/100 vs national avg 83.1

0%100%National avg83%76.5%
MIPS final score (Oncology Registered Nurse) — 76.5025/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANALUISA LARES, NP is a Oncology Registered Nurse provider practicing in STANFORD, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: NP. NPI: 1518333202. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANALUISA LARES, NP appears in the CMS NPPES registry as a Oncology Registered Nurse provider holding NP credentials at 900 BLAKE WILBUR DR, STANFORD, CA, 94305, with a listed phone of (650) 725-3292. NPI 1518333202 was issued on 08/17/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LARES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 50 prescription claims written by this provider, covering 16 Medicare beneficiaries and totaling roughly $3K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.5025/100 for the 2023 performance year (Quality 74.3195, Cost 43.9595), compared with the national average of 83.1.

Oncology Registered Nurse is a narrow specialty nationwide, with 857 enrolled providers across 50 states and an average of 555 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

900 BLAKE WILBUR DR
STANFORD, CA 94305

Provider Details

NPI 1518333202
Specialty Oncology Registered Nurse
Credentials NP
Gender Female
NPI Issued 08/17/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.5025
Final Score
Avg: 83.1
74.3195
Quality
43.9595
Cost
100
Promoting Interoperability

Reporting: Group practice

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ANALUISA LARES, NP. To verify ANALUISA LARES, NP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

50
Total Claims
$3K
Total Drug Cost
16
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
64
Total Day Supply
1,721
Brand Drug Cost
$0
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
77.2 years
Avg HCC Risk Score
1.92

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluocinonide
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Registered Nurse Overview

How ANALUISA LARES, NP fits within the Oncology Registered Nurse landscape nationally.

857
Oncology Registered Nurse Providers in US
50
States with Oncology Registered Nurse
555
Avg Claims per Provider

ANALUISA LARES, NP's 50 claims are below the specialty average of 555.

Nearby Oncology Registered Nurse Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LARES.

Compare Oncology Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANALUISA LARES, NP's specialty?
ANALUISA LARES, NP specializes in Oncology Registered Nurse and practices in STANFORD, California. Credentials: NP.
How much does ANALUISA LARES, NP prescribe under Medicare Part D?
In 2023, ANALUISA LARES, NP wrote 50 Medicare Part D claims totaling $3K in drug costs for 16 beneficiaries.
What is ANALUISA LARES, NP's Medicare quality score?
ANALUISA LARES, NP has a CMS MIPS Final Score of 76.5025/100 (Quality: 74.3195, Cost: 43.9595). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANALUISA LARES, NP located?
ANALUISA LARES, NP is located at 900 BLAKE WILBUR DR, STANFORD, CA, 94305. Phone: (650) 725-3292.
What is ANALUISA LARES, NP's NPI number?
ANALUISA LARES, NP's National Provider Identifier (NPI) is 1518333202, issued on 08/17/2015.
How many Oncology Registered Nurse providers are there in the US?
There are 857 Oncology Registered Nurse providers across 50 states in the US. The average Oncology Registered Nurse provider writes 555 Medicare Part D claims per year.
What drugs does ANALUISA LARES, NP prescribe most often?
Based on 2023 Medicare Part D data, ANALUISA LARES, NP's most frequently prescribed drugs include Fluocinonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANALUISA LARES, NP accept Medicare?
ANALUISA LARES, NP appears in CMS Medicare data with 50 Part D claims and 16 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANALUISA LARES, NP's credentials?
ANALUISA LARES, NP's NPI is 1518333202 with credentials NP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology